Abstract
The entorhinal cortex has been implicated in the early stages of Alzheimer's disease, which is characterized by changes in the tau protein and in the cleaved fragments of the amyloid precursor protein (APP). We used a high-resolution functional magnetic resonance imaging (fMRI) variant that can map metabolic defects in patients and mouse models to address basic questions about entorhinal cortex pathophysiology. The entorhinal cortex is divided into functionally distinct regions, the medial entorhinal cortex (MEC) and the lateral entorhinal cortex (LEC), and we exploited the high-resolution capabilities of the fMRI variant to ask whether either of them was affected in patients with preclinical Alzheimer's disease. Next, we imaged three mouse models of disease to clarify how tau and APP relate to entorhinal cortex dysfunction and to determine whether the entorhinal cortex can act as a source of dysfunction observed in other cortical areas. We found that the LEC was affected in preclinical disease, that LEC dysfunction could spread to the parietal cortex during preclinical disease and that APP expression potentiated tau toxicity in driving LEC dysfunction, thereby helping to explain regional vulnerability in the disease.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
206,07 € per year
only 17,17 € per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout







Similar content being viewed by others
Accession codes
References
Braak, H. & Del Tredici, K. Alzheimer's disease: pathogenesis and prevention. Alzheimers Dement. 8, 227–233 (2012).
Gómez-Isla, T. et al. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J. Neurosci. 16, 4491–4500 (1996).
Whitwell, J.L. et al. 3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease. Brain 130, 1777–1786 (2007).
Moreno, H. et al. Imaging the abeta-related neurotoxicity of Alzheimer disease. Arch. Neurol. 64, 1467–1477 (2007).
Näslund, J. et al. Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. J. Am. Med. Assoc. 283, 1571–1577 (2000).
Lue, L.F. et al. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am. J. Pathol. 155, 853–862 (1999).
Desikan, R.S. et al. Amyloid-beta–associated clinical decline occurs only in the presence of elevated P-tau. Arch. Neurol. 69, 709–713 (2012).
Canto, C.B. & Witter, M.P. Cellular properties of principal neurons in the rat entorhinal cortex. I. The lateral entorhinal cortex. Hippocampus 22, 1256–1276 (2012).
Canto, C.B. & Witter, M.P. Cellular properties of principal neurons in the rat entorhinal cortex. II. The medial entorhinal cortex. Hippocampus 22, 1277–1299 (2012).
Tsao, A., Moser, M.B. & Moser, E.I. Traces of experience in the lateral entorhinal cortex. Curr. Biol. 23, 399–405 (2013).
Canto, C.B., Wouterlood, F.G. & Witter, M.P. What does the anatomical organization of the entorhinal cortex tell us? Neural Plast. 2008, 381243 (2008).
Selkoe, D.J. Alzheimer's disease is a synaptic failure. Science 298, 789–791 (2002).
Sperling, R.A. et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 7, 280–292 (2011).
Lin, W., Celik, A. & Paczynski, R.P. Regional cerebral blood volume: a comparison of the dynamic imaging and the steady state methods. J. Magn. Reson. Imaging 9, 44–52 (1999).
Raichle, M.E. Positron emission tomography. Annu. Rev. Neurosci. 6, 249–267 (1983).
Belliveau, J.W. et al. Functional mapping of the human visual cortex by magnetic resonance imaging. Science 254, 716–719 (1991).
González, R.G. et al. Functional MR in the evaluation of dementia: correlation of abnormal dynamic cerebral blood volume measurements with changes in cerebral metabolism on positron emission tomography with fludeoxyglucose F 18. AJNR Am. J. Neuroradiol. 16, 1763–1770 (1995).
Small, S.A., Chawla, M.K., Buonocore, M., Rapp, P.R. & Barnes, C.A. From the cover: imaging correlates of brain function in monkeys and rats isolates a hippocampal subregion differentially vulnerable to aging. Proc. Natl. Acad. Sci. USA 101, 7181–7186 (2004).
Liu, L. et al. Trans-synaptic spread of tau pathology in vivo. PLoS ONE 7, e31302 (2012).
de Calignon, A. et al. Propagation of tau pathology in a model of early Alzheimer's disease. Neuron 73, 685–697 (2012).
Harris, J.A. et al. Transsynaptic progression of amyloid-beta–induced neuronal dysfunction within the entorhinal-hippocampal network. Neuron 68, 428–441 (2010).
Sabuncu, M.R., Yeo, B.T., Van Leemput, K., Vercauteren, T. & Golland, P. Asymmetric image-template registration. Med. Image Comput. Comput. Assist. Interv. 12, 565–573 (2009).
Brickman, A.M., Stern, Y. & Small, S.A. Hippocampal subregions differentially associate with standardized memory tests. Hippocampus 21, 923–928 (2011).
Elias, M.F. et al. The preclinical phase of alzheimer disease: a 22-year prospective study of the Framingham Cohort. Arch. Neurol. 57, 808–813 (2000).
Yasuda, M. & Mayford, M.R. CaMKII activation in the entorhinal cortex disrupts previously encoded spatial memory. Neuron 50, 309–318 (2006).
Moreno, H., Hua, F., Brown, T. & Small, S. Longitudinal mapping of mouse cerebral blood volume with MRI. NMR Biomed. 19, 535–543 (2006).
Lewis, J. et al. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 293, 1487–1491 (2001).
Jicha, G.A., Berenfeld, B. & Davies, P. Sequence requirements for formation of conformational variants of tau similar to those found in Alzheimer's disease. J. Neurosci. Res. 55, 713–723 (1999).
Hevner, R.F. & Wong-Riley, M.T. Entorhinal cortex of the human, monkey, and rat: metabolic map as revealed by cytochrome oxidase. J. Comp. Neurol. 326, 451–469 (1992).
Solodkin, A. & Van Hoesen, G.W. Entorhinal cortex modules of the human brain. J. Comp. Neurol. 365, 610–617 (1996).
Kageyama, G.H. & Wong-Riley, M.T. Histochemical localization of cytochrome oxidase in the hippocampus: correlation with specific neuronal types and afferent pathways. Neuroscience 7, 2337–2361 (1982).
Schon, K., Hasselmo, M.E., Lopresti, M.L., Tricarico, M.D. & Stern, C.E. Persistence of parahippocampal representation in the absence of stimulus input enhances long-term encoding: a functional magnetic resonance imaging study of subsequent memory after a delayed match-to-sample task. J. Neurosci. 24, 11088–11097 (2004).
Olsen, R.K. et al. Performance-related sustained and anticipatory activity in human medial temporal lobe during delayed match-to-sample. J. Neurosci. 29, 11880–11890 (2009).
Suzuki, W.A. & Amaral, D.G. Perirhinal and parahippocampal cortices of the macaque monkey: cortical afferents. J. Comp. Neurol. 350, 497–533 (1994).
Young, B.J., Otto, T., Fox, G.D. & Eichenbaum, H. Memory representation within the parahippocampal region. J. Neurosci. 17, 5183–5195 (1997).
Albert, M.S. The ageing brain: normal and abnormal memory. Phil. Trans. R. Soc. Lond. B 352, 1703–1709 (1997).
Petersen, R.C., Smith, G., Kokmen, E., Ivnik, R.J. & Tangalos, E.G. Memory function in normal aging. Neurology 42, 396–401 (1992).
Stranahan, A.M., Haberman, R.P. & Gallagher, M. Cognitive decline is associated with reduced reelin expression in the entorhinal cortex of aged rats. Cereb. Cortex 21, 392–400 (2011).
Meguro, K. et al. Neocortical and hippocampal glucose hypometabolism following neurotoxic lesions of the entorhinal and perirhinal cortices in the non-human primate as shown by PET. Implications for Alzheimer's disease. Brain 122, 1519–1531 (1999).
Klunk, W.E. et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann. Neurol. 55, 306–319 (2004).
Kageyama, G.H. & Wong-Riley, M.T. Histochemical localization of cytochrome oxidase in the hippocampus: correlation with specific neuronal types and afferent pathways. Neuroscience 7, 2337–2361 (1982).
Das, U. et al. Activity-induced convergence of APP and BACE-1 in acidic microdomains via an endocytosis-dependent pathway. Neuron 79, 447–460 (2013).
Ittner, L.M. et al. Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models. Cell 142, 387–397 (2010).
Sapir, T., Frotscher, M., Levy, T., Mandelkow, E.M. & Reiner, O. Tau's role in the developing brain: implications for intellectual disability. Hum. Mol. Genet. 21, 1681–1692 (2012).
Brickman, A.M. et al. Brain morphology in older African Americans, Caribbean Hispanics, and whites from northern Manhattan. Arch. Neurol. 65, 1053–1061 (2008).
Stern, Y. et al. Diagnosis of dementia in a heterogeneous population. Development of a neuropsychological paradigm-based diagnosis of dementia and quantified correction for the effects of education. Arch. Neurol. 49, 453–460 (1992).
McKhann, G. et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939–944 (1984).
Hughes, C.P., Berg, L., Danziger, W.L., Coben, L.A. & Martin, R.L. A new clinical scale for the staging of dementia. Br. J. Psychiatry 140, 566–572 (1982).
Manly, J.J. et al. Frequency and course of mild cognitive impairment in a multiethnic community. Ann. Neurol. 63, 494–506 (2008).
Santacruz, K. et al. Tau suppression in a neurodegenerative mouse model improves memory function. Science 309, 476–481 (2005).
Jankowsky, J.L. et al. Environmental enrichment mitigates cognitive deficits in a mouse model of Alzheimer's disease. J. Neurosci. 25, 5217–5224 (2005).
Moreno, H., Hua, F., Brown, T. & Small, S. Longitudinal mapping of mouse cerebral blood volume with MRI. NMR Biomed. 19, 535–543 (2006).
Reuter, M., Rosas, H.D. & Fischl, B. Highly accurate inverse consistent registration: a robust approach. Neuroimage 53, 1181–1196 (2010).
Frangi, A., Niessen, W., Vincken, K. & Viergever, M. Multiscale vessel enhancement filtering. Med. Image Comput. Comput, Assist. Interv. 1496, 130–137 (1998).
Desikan, R.S. et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 31, 968–980 (2006).
Tustison, N.J. et al. N4ITK: improved N3 bias correction. IEEE Trans. Med. Imaging 29, 1310–1320 (2010).
Richards, K. et al. Segmentation of the mouse hippocampal formation in magnetic resonance images. Neuroimage 58, 732–740 (2011).
Zeineh, M.M., Engel, S.A. & Bookheimer, S.Y. Application of cortical unfolding techniques to functional MRI of the human hippocampal region. Neuroimage 11, 668–683 (2000).
Mueller, S.G. et al. Measurement of hippocampal subfields and age-related changes with high resolution MRI at 4T. Neurobiol. Aging 28, 719–726 (2007).
Paxinos, G. & Franklin, K. The Mouse Brain in Stereotaxic Coordinates (Academic Press, 2001).
Acknowledgements
This work was supported by US National Institutes of Health grants AG034618 and AG025161 to S.A.S., AG07232 and AG037212 to R.M., NS074874 to K.E.D., and HL094423 to R.S.
Author information
Authors and Affiliations
Contributions
U.A.K. performed the mouse and human fMRI analysis and wrote the manuscript. L.L. helped with mouse breeding and performed the histological analyses in mice models. F.A.P. performed the human fMRI post-processing. D.E.B. performed the microarray and other molecular analyses. C.P.P. helped with the histological analyses and mouse breeding. R.S. recruited the young human subjects. R.M. recruited and characterized the older human subjects. K.E.D. supervised the generation and histological analyses in the mouse models and wrote the manuscript. S.A.S. designed the studies, helped with the statistical analyses and wrote the manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Khan, U., Liu, L., Provenzano, F. et al. Molecular drivers and cortical spread of lateral entorhinal cortex dysfunction in preclinical Alzheimer's disease. Nat Neurosci 17, 304–311 (2014). https://doi.org/10.1038/nn.3606
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nn.3606
This article is cited by
-
Expression patterns of AEG-1 in the normal brain
Brain Structure and Function (2023)
-
A deep learning MRI approach outperforms other biomarkers of prodromal Alzheimer’s disease
Alzheimer's Research & Therapy (2022)
-
Accumulation of C-terminal cleaved tau is distinctly associated with cognitive deficits, synaptic plasticity impairment, and neurodegeneration in aged mice
GeroScience (2022)
-
Does the Application of Deep Brain Stimulation to Modulate Memory and Neural Circuity in AD Hold Substantial Promise?
Neuroscience Bulletin (2022)
-
Diagnostic performance of hippocampal volumetry in Alzheimer’s disease or mild cognitive impairment: a meta-analysis
European Radiology (2022)